Skip to main content

Published locations for Vedolizumab Beats Infliximab as Second-Line Therapy for Ulcerative Colitis

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Vedolizumab Beats Infliximab as Second-Line Therapy for Ulcerative Colitis

User login

  • Reset your password
  • /content/vedolizumab-beats-infliximab-second-line-therapy-ulcerative-colitis
  • /content/vedolizumab-beats-infliximab-second-line-therapy-ulcerative-colitis
  • /gihepnews/article/272320/ibd-intestinal-disorders/vedolizumab-beats-infliximab-second-line-therapy-ulcerative-colitis
  • /taxonomy/term/79117/article/272320/ibd-intestinal-disorders/vedolizumab-beats-infliximab-second-line-therapy-ulcerative-colitis